Using filgrastim efficiently.
Dranitsaris
G
G
D000970:Antineoplastic Agents / Q000009:adverse effects; D003362:Cost-Benefit Analysis; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use